Sandu Pharmaceuticals Limited (BOM:524703)
India · Delayed Price · Currency is INR 42.90
-0.20 (-0.46%)
At close: Jun 17, 2026
Sandu Pharmaceuticals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 16, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 414 | 295 | 473 | 554 | 593 | 620 | |
Market Cap Growth | -22.48% | -37.70% | -14.64% | -6.51% | -4.32% | 144.92% |
Enterprise Value | 350 | 262 | 445 | 512 | 532 | 582 |
Last Close Price | 42.90 | 30.52 | 48.19 | 55.75 | 50.20 | 66.93 |
PE Ratio | 23.44 | 16.70 | 30.50 | 37.94 | 39.01 | 39.00 |
PS Ratio | 0.59 | 0.42 | 0.70 | 0.82 | 0.91 | 0.95 |
PB Ratio | 0.95 | 0.68 | 1.13 | 1.37 | 1.51 | 1.70 |
P/TBV Ratio | 0.95 | 0.68 | 1.13 | 1.37 | 1.51 | 1.70 |
P/FCF Ratio | 7.68 | 5.46 | 4550.88 | - | - | 575.52 |
P/OCF Ratio | 6.78 | 4.82 | 49.90 | 72.96 | 268.24 | 65.33 |
EV/Sales Ratio | 0.50 | 0.38 | 0.66 | 0.76 | 0.81 | 0.89 |
EV/EBITDA Ratio | 11.67 | 8.74 | 17.52 | 24.03 | 22.90 | 21.61 |
EV/EBIT Ratio | 15.07 | 11.28 | 21.25 | 29.90 | 27.02 | 24.85 |
EV/FCF Ratio | 6.49 | 4.86 | 4279.97 | - | - | 540.75 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.00 | - | - |
Debt / EBITDA Ratio | 0.14 | 0.14 | 0.17 | 0.03 | - | - |
Debt / FCF Ratio | 0.08 | 0.08 | 45.91 | - | - | - |
Net Debt / Equity Ratio | -0.15 | -0.15 | -0.05 | -0.03 | -0.06 | -0.11 |
Net Debt / EBITDA Ratio | -2.14 | -2.14 | -0.86 | -0.54 | -0.99 | -1.55 |
Net Debt / FCF Ratio | -1.19 | -1.19 | -209.18 | 1.72 | 2.71 | -38.73 |
Asset Turnover | 1.25 | 1.25 | 1.24 | 1.26 | 1.26 | 1.36 |
Inventory Turnover | 2.57 | 2.57 | 2.59 | 2.61 | 2.60 | 3.38 |
Quick Ratio | 1.18 | 1.18 | 0.62 | 0.58 | 0.53 | 0.72 |
Current Ratio | 2.43 | 2.43 | 2.18 | 2.10 | 1.84 | 1.99 |
Return on Equity (ROE) | 4.12% | 4.12% | 3.76% | 3.66% | 4.02% | 4.54% |
Return on Assets (ROA) | 2.60% | 2.60% | 2.42% | 2.01% | 2.38% | 3.04% |
Return on Invested Capital (ROIC) | 4.06% | 4.01% | 3.80% | 3.16% | 3.90% | 5.94% |
Return on Capital Employed (ROCE) | 5.10% | 5.10% | 4.80% | 4.10% | 4.90% | 6.30% |
Earnings Yield | 4.26% | 5.99% | 3.28% | 2.63% | 2.56% | 2.56% |
FCF Yield | 13.02% | 18.30% | 0.02% | -1.20% | -1.43% | 0.17% |
Dividend Yield | 2.33% | 3.28% | 1.66% | 1.44% | 1.49% | 1.12% |
Payout Ratio | 43.76% | 43.76% | 49.81% | 49.59% | 43.46% | 19.94% |
Buyback Yield / Dilution | 0.10% | 0.10% | - | -2.42% | -10.93% | -20.08% |
Total Shareholder Return | 2.43% | 3.38% | 1.66% | -0.98% | -9.44% | -18.96% |